Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cipla
McKesson
Medtronic
Deloitte
Harvard Business School
Dow
Fish and Richardson
Cantor Fitzgerald
US Army

Generated: December 10, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,027,967

« Back to Dashboard

Which drugs does patent 9,027,967 protect, and when does it expire?


Patent 9,027,967 protects COMBIVENT RESPIMAT, STIOLTO RESPIMAT, STRIVERDI RESPIMAT, and SPIRIVA RESPIMAT, and is included in four NDAs.

Protection for SPIRIVA RESPIMAT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-five patent family members in twenty-five countries.

Summary for Patent: 9,027,967

Title:Device for clamping a fluidic component
Abstract: A fluidic component is arranged in an elastomeric shaped part the contour of which is matched to the outer contour of the component and to the inner contour of a holder. The elastomeric shaped part is chamfered towards the fluidic component on its pressure side. When the holder is assembled the elastomeric shaped part is deformed by a projection provided on a mating part and is put under uniformly distributed internal tension, after which the elastomeric shaped part surrounds the fluidic component to its full height.
Inventor(s): Geser; Johannes (Ingelheim, DE), Hausmann; Matthias (Dortmund, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:12/641,424
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes► Subscribe► Subscribe► SubscribeY
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes► Subscribe► Subscribe► SubscribeY
Boehringer IngelheimSTRIVERDI RESPIMATolodaterol hydrochlorideSPRAY, METERED;INHALATION203108-001Jul 31, 2014RXYesYes► Subscribe► Subscribe► SubscribeY
Boehringer IngelheimSPIRIVA RESPIMATtiotropium bromideSPRAY, METERED;INHALATION021936-002Sep 15, 2015RXYesNo► Subscribe► Subscribe► SubscribeY
Boehringer IngelheimSPIRIVA RESPIMATtiotropium bromideSPRAY, METERED;INHALATION021936-001Sep 24, 2014RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 9,027,967

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany10 2004 001 451Jan 8, 2004

Non-Orange Book Patents for Patent: 9,027,967

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,837,235Device for clamping a fluidic component► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 9,027,967

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China1921949► Subscribe
Colombia5700802► Subscribe
Cyprus1107900► Subscribe
Germany102004001451► Subscribe
Germany502004005733► Subscribe
Denmark1706210► Subscribe
Eurasian Patent Organization200601207► Subscribe
Eurasian Patent Organization008630► Subscribe
EcuadorSP066691► Subscribe
Egypt25014► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Dow
Chinese Patent Office
Queensland Health
Federal Trade Commission
Daiichi Sankyo
Mallinckrodt
Julphar
Chubb
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot